(Q51413964)

5 April 2018

title

Ethinylestradiol/Chlormadinone acetate for use in dermatological disorders. (English)

1 reference

5 April 2018

author name string

Mercedes Gómez Vázquez

1

1 reference

5 April 2018

Ramón Navarra Amayuelas

2

1 reference

5 April 2018

Marta Lamarca

3

1 reference

5 April 2018

Laura Baquedano

4

1 reference

5 April 2018

Sebastián Romero Ruiz

5

1 reference

5 April 2018

Eduardo Vilar-Checa

6

1 reference

5 April 2018

Maria D Iniesta

7

1 reference

5 April 2018

publication date

1 September 2011

1 reference

5 April 2018

American Journal of Clinical Dermatology

published in

1 reference

5 April 2018

volume

12 Suppl 1

1 reference

5 April 2018

page(s)

13-19

1 reference

5 April 2018

https://scigraph.springernature.com/pub.10.2165/1153875-s0-000000000-00000

exact match

0 references

cites work

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

Androgenetic alopecia in women

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

Management of androgenetic alopecia in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

Female pattern hair loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

Clinical practice. Hirsutism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

Hirsutism and acne in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

Finasteride for female androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

Treatment of female pattern hair loss with oral antiandrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

Long-term efficacy and safety of a monophasic combined oral contraceptive containing 0.02 mg ethinylestradiol and 2 mg chlormadinone acetate administered in a 24/4-day regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

Efficacy of an oral contraceptive containing EE 0.03 mg and CMA 2 mg (Belara) in moderate acne resolution: a randomized, double-blind, placebo-controlled Phase III trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

Safety data and beneficial effects of the combined oral contraceptive ethinylestradiol 0.03 mg/chlormadinone acetate 2 mg (Belara®): a 13-cycle, observational study in routine clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

Noncontraceptive benefits of two combined oral contraceptives with antiandrogenic properties among adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

Efficacy, safety and sustainability of treatment continuation and results of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg chlormadinone acetate, in long-term usage (up to 45 cycles)--an open-label, prospective, noncontrolled, o

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

Acne: effect of hormones on pathogenesis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

Acne resolution rates: results of a single-blind, randomized, controlled, parallel phase III trial with EE/CMA (Belara) and EE/LNG (Microgynon).

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

Ethinylestradiol/Chlormadinone acetate: dermatological benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F1153875-S0-000000000-00000

The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

A review of hormonal therapy for female pattern (androgenic) alopecia.

1 reference

12 December 2020

Polycystic ovary syndrome

1 reference

12 December 2020

Combined oral contraceptive pills for treatment of acne

1 reference

12 December 2020

Acne vulgaris, I: pathogenesis and diagnosis

1 reference

12 December 2020

Current concepts in the treatment of acne: report from a clinical roundtable.

1 reference

12 December 2020

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

1 reference

12 December 2020

Androgenetic alopecia in the female. Treatment with 2% topical minoxidil solution

1 reference

12 December 2020

The effect of cyproterone acetate on hair roots and hair shaft diameter in androgenetic alopecia in females

1 reference

12 December 2020

10.2165/1153875-S0-000000000-00000

Identifiers

DOI

1 reference

5 April 2018

Dimensions Publication ID

1001897203

0 references

1 reference

5 April 2018